概述 Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome HER3 augmentation via blockade of EGFR/AKT signaling enhances anticancer activity of HER3-targeting Patritumab Deruxtecan in EGFR-mutated non-small cell lung cancer First-in-class anti-immunoglobulin-like transcript 4 myeloid-specific antibody MK-4830 abrogates a PD-1 resistance mechanism in patients with advanced solid tumors

概述 TruSight Oncology Comprehensive（EU） TruSight Oncology 500产品系列 TruSight Oncology 500产品系列 MRD（分子残留病灶）产品（开发中）

概述 多组学推动药物靶点发现应用实例 多组学在药物开发中的潜力 将多组学方法应用于药物靶点验证 多组学在药物靶点验证中的应用实例